Harnessing Epigenetics for Advanced Cancer Detection
Timely cancer detection paves the way for interventions that are less toxic, less disruptive, and less costly than treatment in later stages.
Read MorePosted by Chris Wolski | Nov 15, 2023 | Cancer |
Timely cancer detection paves the way for interventions that are less toxic, less disruptive, and less costly than treatment in later stages.
Read MorePosted by Andy Lundin | Nov 14, 2023 | Molecular Diagnostic Analyzers |
BIOTYPE presented a major upgrade to its benchtop diagnostic platform for the fully integrated analysis of molecular biomarker signatures.
Read MorePosted by Chris Wolski | Nov 14, 2023 | Breast |
PreciseBreast, an AI-powered digital morphology tool, has a fast turnaround time and is cost-effective compared to gene expression tests.
Read MorePosted by Andy Lundin | Nov 14, 2023 | Molecular Diagnostics |
A special kind of genetic testing that determines the best antidepressant for patients with depression may greatly improve patient outcomes.
Read MorePosted by Andy Lundin | Nov 9, 2023 | Diagnostic Technologies, Disease States |
Roche’s Elecsys NfL test for MS received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).
Read More